This Is Why AJ Lucas Group Limited (ASX: AJL) Great Boulder Resources Ltd (ASX: GBR) and Biotron Limited (ASX: BIT) Rallied

Sector Reports > Latest News > ASX > This Is Why AJ Lucas Group Limited (ASX: AJL) Great Boulder Resources Ltd (ASX: GBR) and Biotron Limited (ASX: BIT) Rallied

Sector Reports are pleased to announce our coverage on the below stocks.

For daily updates, news, trade ideas and complimentary research reports please insert your email in the box below and get instant access to our latest research reports, which include Cannabis, AI, Gold, Gambling and more.

AJ Lucas Group Limited (ASX: AJL) Great Boulder Resources Ltd (ASX: GBR) and Biotron Limited (ASX: BIT) were big movers in Tuesday’s trading session. Investors reacted to a series of positive news.

Enter Your Email for Instant Access to the Best Free ASX Research on the Markets

Great Boulder Mt Carlon Project Discoveries

Great Boulder stock was up by more than 30% as investors reacted to the discovery of two strong and large anomalies as part of its ongoing exploration works at Mt Carlon project. The Eastern Zone anomaly has already shown great prospects with elevated levels of nickel in ultramafic rocks. The western zone of the project, which comprises of 3.5 km long linear zone, has shown prospects of gold mineralization

According to the managing director Andrew Paterson, the anomalies are highly promising. Plans are underway to conduct further field reconnaissance. The company is also planning to conduct soil and rock chip sampling, which should pave the way for surface geophysical surveys.

The discovery in Mt Carlon project comes just days after the company confirmed plans to commence first round of drilling in priority targets at the Whiteheads gold project. The company is also preparing for the next round of drilling at the Tarmoola project.

AJ Lucas Loan Note Facility Extension

AJ Lucas was up by more than 10%, a day after confirming that it has reached an agreement that paves the way for it to amend terms associated with its Loan Note facility. OCP Asia, the debt provider, has agreed to defer the pay-down requirement of a $20 million loan facility to October 25, 2019, from September 30, 2019.

The extension opens the door for the company to continue negotiations with a select group of new lenders about the possibility of refinancing the existing Loan Note facility. Negotiations are currently at an advanced stage. AJ Luca is relying on a new deal to help get rid of the current loan facility with a much cheaper debt package over the next three years.

AJ Lucas recently reported financial results for the year ended June 30, 2019, whereby statutory EBITDA profit was down to $9.1 million from $21 million reported a year earlier. The decline stems from an increase in costs associated with drilling and fracturing by Cuadrilla Resources Holdings in the UK.

“Our investment in UK Shale Gas exploration saw some positive results with a flow test of the first well at Preston New Road yielding high quality dry natural gas and indications of extrapolated stable flow under operating conditions,” SAID Chairman Phil Arnall.

Biotron Limited Advisory Board Formation

Biotron was a big mover after announcing the establishment of an expert Scientific Advisory Board. The board is tasked with the responsibility of spearheading and overseeing the upcoming Phase 2 HIV-1 clinical development program.

Chaired By professor Robert L Murphy, the board includes an international group of experts with vast experience in matters pertaining to HIV-1 as well as clinical development of HIV-1 therapies. The formation of the board comes hot on the heels of the company reporting positive results as part of BIT225-009 phase 2 HIV-1 clinical trial.

Enter Your Email for Instant Access to the Best Free ASX Research on the Markets



This website is a service of Profectus Solutions Pty. Ltd. an investor relations group and media firm. The website or article has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. Profectus is not responsible for material posted on this website and does not guarantee the content, accuracy, or use of the content in this site. No advice or information, whether oral or written, obtained by you from Profectus Solutions or through or from the service shall create any warranty not expressly stated.

Profectus Solutions do not offer financial advice based upon your personal financial situation or goals, and we shall NOT be held liable for any investment or trading losses you may incur by using the opinions expressed in our publications, market updates, news alerts and corporate profiles. Profectus does not in any way endorse or recommend individuals, products or services that may be discussed on this site. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a professional licensed financial planner and adviser. Our publications are NOT a solicitation or recommendation to buy, sell or hold. We are neither licensed nor qualified to provide investment advice.

Conflict of interest

Directors, staff or third parties of Profectus may at times own shares of companies that are profiled within our network. We as part of our business model actively seek to do business with listed ASX or other companies.

We have NOT been compensated for the production of this webpage.

Leave a Reply

Your email address will not be published.